Clinical Trial Update: Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops [Phase 1]

View source ↗

Summary

This is a Phase 1 study evaluating the safety and tolerability of SCAI-005 Eye Drops for Wet Age-Related Macular Degeneration. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• SCAI-005 Eye Drops

Snippet

Sponsor: SCAI Therapeutics | Conditions: Wet Age Related Macular Degeneration | Phase 1 | Status: COMPLETED